ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    “THE STUDY OF PROCALCITONIN AS EARLY BIOMARKER OF SEPSIS IN DIABETIC KETOACIDOSIS AT A TERTIARY CENTRE IN JAIPUR”


    Dr. Narendra Kumar Dr. Sudhir Bhandari Dr Ajeet Singh Dr.Suresh Yadav
    JCDR. 2023: 355-367

    Abstract

    Diabetic ketoacidosis (DKA) is one of the most serious complications of diabetes mellitus (DM). Precise early prediction of infection and its severity in diabetic patients serves an important role in improving infection control and prognosis. Procalcitonin (PCT), a marker of the inflammatory response during infections, can be elevated by diabetic ketoacidosis (DKA). Early detection and treatment of infections are key elements to improved patient outcomes, and as such, empiric antibiotics are frequently prescribed to patients who present with DKA.

    Description

    » PDF

    Volume & Issue

    Volume 14 Issue 9

    Keywords